Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine

Jonathan Uy, Rong Yang, Victoria Wirtz, Louise Sheppard, Awny Farajallah, Donnie McGrath
  • AIDS Care, November 2011, Taylor & Francis
  • DOI: 10.1080/09540121.2011.565033

In partnership with: